orphan drugs

No slowing down: Orphan drug designations skyrocket in 2017
No slowing down: Orphan drug designations skyrocket in 2017
Medical Marketing and Media
orphan drugs
FDA
Flag link:
Analyzing the orphan drugs market ($127bn)
Analyzing the orphan drugs market ($127bn)
GoinPharma
orphan drugs
Shire
Baxalta
Sanofi
Bioverativ
M&A
Flag link:
FDA to Launch New Pilot Program for Orphan Designation Requests
FDA to Launch New Pilot Program for Orphan Designation Requests
RAPS.org
FDA
orphan drugs
Flag link:
Despite increased spending, orphan drugs still small piece of US medicines market
Despite increased spending, orphan drugs still small piece of US medicines market
Biopharma Dive
orphan drugs
drug pricing
Flag link:
FDA is Advancing the Goals of the Orphan Drug Act
FDA is Advancing the Goals of the Orphan Drug Act
FDA Voice
FDA
orphan drugs
Orphan Drug Act
Flag link:
FDA Determines that Deuterated Compounds are NCEs and Different Orphan Drugs Versus Non-deuterated Versions
FDA Determines that Deuterated Compounds are NCEs and Different Orphan Drugs Versus Non-deuterated Versions
FDA Law Blog
FDA
deuterated drugs
NCEs
Austedo
Teva Pharmaceutical
orphan drugs
Flag link:
FDA Plots Elimination of the Orphan Drug Designation Request Backlog
FDA Plots Elimination of the Orphan Drug Designation Request Backlog
RAPS.org
FDA
orphan drugs
Flag link:
Orphan drug market set to climb above $200B: Report
Orphan drug market set to climb above $200B: Report
Fierce Pharma
orphan drugs
Flag link:
FDA User Fee Package Includes “Technical Corrections” to Address Orphan Drug Clinical Superiority
FDA User Fee Package Includes “Technical Corrections” to Address Orphan Drug Clinical Superiority
FDA Law Blog
FDA
orphan drugs
Flag link:
Celgene, BMS, Novartis expected to top 2022 orphan drug market worth $209B: report
Celgene, BMS, Novartis expected to top 2022 orphan drug market worth $209B: report
Fierce Pharma
Celgene
Novartis
Bristol-Myers Squibb
orphan drugs
Revlimid
Flag link:
Grunenthal snags a PhIII-ready orphan drug in Thar Pharma buyout
Grunenthal snags a PhIII-ready orphan drug in Thar Pharma buyout
Endpoints
Grunenthal
Thar Pharmaceuticals
T121
orphan drugs
Flag link:
Ionis’s Orphan Drug in Third Phase of Clinical Trials
Ionis’s Orphan Drug in Third Phase of Clinical Trials
Market Realist
Ionis Pharmaceuticals
clinical trials
orphan drugs
Volanesorsen
Flag link:
Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302
Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302
Yahoo
Galeana Biopharma
orphan drugs
ovarian cancer
GALE-301
GALE-301/GALE-302
Flag link:
Just When FDA Thought It Was Out, They Pull It Back In: AstraZeneca Raises 505A(o) and Orphan Drug Exclusivity Carve-Outs in CRESTOR Petition
Just When FDA Thought It Was Out, They Pull It Back In: AstraZeneca Raises 505A(o) and Orphan Drug Exclusivity Carve-Outs in CRESTOR Petition
FDA Law Blog
FDA
orphan drugs
Crestor
505A(o)
Flag link:
FDA More Than Doubles the Number of Orphan Drug Designation Revocations Overnight
FDA More Than Doubles the Number of Orphan Drug Designation Revocations Overnight
FDA Law Blog
FDA
orphan drugs
Flag link:
Why Has Teva Pharmaceutical Targeted Orphan Diseases?
Why Has Teva Pharmaceutical Targeted Orphan Diseases?
Yahoo/Market Realist
Teva Pharmaceutical
SD-809
hyperkinetic movement disorders
Huntington's disease
orphan drugs
Flag link:
Oxigene's pancreatic cancer treatments granted orphan drug status in Europe
Oxigene's pancreatic cancer treatments granted orphan drug status in Europe
Marketwatch
Oxigene
pancreatic cancer
orphan drugs
CA4P
Flag link:
Orphan Drugs On a Roll, A Look Into the 2016 Orphan Space
Orphan Drugs On a Roll, A Look Into the 2016 Orphan Space
Yahoo/Accesswire
AstraZeneca
orphan drugs
ProNai
Delmar Pharma
Bellicum
Flag link:
Looking ahead at orphan drugs' future: More breakthroughs, exploding sales
Looking ahead at orphan drugs' future: More breakthroughs, exploding sales
BioPharma Dive
orphan drugs
Sumitomo Dainippon
obeticholic acid
AbbVie
venetoclax
Actelion
Uptravi
Flag link:
Orphan drug sales expected to grow 12% by 2020
Orphan drug sales expected to grow 12% by 2020
Medical Marketing and Media
orphan drugs
Flag link:

Pages